Dizal
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (36)
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Started: 9/8/2025
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Started: 5/13/2024
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
Started: 12/13/2022
A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)
Started: 1/15/2026
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
Started: 6/1/2023
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
Started: 9/22/2025
DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Started: 4/29/2024
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
Started: 2/15/2023
DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)
Started: 3/13/2024
AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)
Started: 5/31/2022
AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)
Started: 3/17/2022
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
Started: 7/19/2021
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
Started: 4/15/2026
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
Started: 8/19/2025
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
Started: 5/13/2025
A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors
Started: 1/29/2026
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
Started: 6/12/2024
DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
Started: 7/16/2025
DZD8586 in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Started: 5/15/2023
A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)
Started: 3/16/2026
Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)
Started: 7/9/2019
Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)
Started: 9/10/2019
DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer
Started: 9/21/2020
Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)
Started: 8/1/2021
A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)
Started: 6/1/2022
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)
Started: 7/31/2023
Drug-drug Interactions Between DZD9008 and Itraconazole/Carbamazepine
Started: 1/25/2022
Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine
Started: 7/27/2022
Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC
Started: 4/12/2021
Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants
Started: 4/21/2021
Pharmacokinetic and Mass Balance Study of Oral-Administrated [14C]-DZD9008 in Healthy Male Subjects
Started: 9/24/2021
Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer
Started: 4/16/2018
Pharmacokinetic and Mass Balance Study of Orally Administered [14C]-AZD4205 in Healthy Adult Male Volunteers
Started: 1/6/2020